News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hakim Nasrat A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/01/2020 |
SC 13D/A
| Hakim Nasrat A reports a 24.2% stake in Elite Pharmaceuticals, Inc. |
| 08/26/2020 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Converted 158,017,321 shares
@ $0
Converted 24 options to buy
@ $0 |
|
| 05/03/2017 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Disposed of 158,017,321 shares
@ $0
Acquired 24 options to buy
@ $1000000, valued at
$24M
Acquired 79,008,661 warrants
@ $0.1521, valued at
$12M
|
|
| 02/27/2017 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 2,216,992 shares
@ $0.2255, valued at
$499.9k
|
|
| 08/19/2016 |
4
| Hakim Nasrat A (CEO & President) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Exercised 100 options to buy
@ $0 |
|
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|